Several other brokerages have also issued reports on EVK. Barclays set a €37.00 ($45.68) price objective on Evonik Industries and gave the company a buy rating in a research report on Wednesday, January 24th. UBS Group set a €27.00 ($33.33) price objective on Evonik Industries and gave the company a sell rating in a research report on Monday, January 22nd. Deutsche Bank set a €40.00 ($49.38) price objective on Evonik Industries and gave the company a buy rating in a research report on Friday, January 5th. JPMorgan Chase & Co. set a €25.00 ($30.86) price objective on Evonik Industries and gave the company a sell rating in a research report on Tuesday, November 14th. Finally, Nord/LB set a €31.00 ($38.27) price objective on Evonik Industries and gave the company a neutral rating in a research report on Friday, December 8th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of €33.74 ($41.65).
Evonik Industries (EVK) opened at €28.77 ($35.52) on Monday. Evonik Industries has a 12-month low of €26.78 ($33.06) and a 12-month high of €32.97 ($40.70). The stock has a market capitalization of $13,380.00 and a P/E ratio of 18.68.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3259152/evonik-industries-evk-pt-set-at-35-00-by-sanford-c-bernstein.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.